Aurinia Pharmaceuticals Inc (AUPH)
4.905
+0.04
(+0.72%)
USD |
NASDAQ |
Apr 26, 16:00
4.905
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals 1 Year Total Returns (Daily): -56.01% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 25, 2024 | -56.01% |
April 24, 2024 | -53.21% |
April 23, 2024 | -52.47% |
April 22, 2024 | -52.85% |
April 19, 2024 | -54.76% |
April 18, 2024 | -56.27% |
April 17, 2024 | -54.37% |
April 16, 2024 | -55.44% |
April 15, 2024 | -55.08% |
April 12, 2024 | -53.76% |
April 11, 2024 | -53.56% |
April 10, 2024 | -49.44% |
April 09, 2024 | -48.17% |
April 08, 2024 | -49.49% |
April 05, 2024 | -49.40% |
April 04, 2024 | -49.85% |
April 03, 2024 | -49.81% |
April 02, 2024 | -53.65% |
April 01, 2024 | -50.73% |
March 28, 2024 | -54.41% |
March 27, 2024 | -53.79% |
March 26, 2024 | -52.18% |
March 25, 2024 | -51.60% |
March 22, 2024 | -43.14% |
March 21, 2024 | -45.60% |
Date | Value |
---|---|
March 20, 2024 | -44.25% |
March 19, 2024 | -45.53% |
March 18, 2024 | -46.48% |
March 15, 2024 | -45.58% |
March 14, 2024 | -46.02% |
March 13, 2024 | -41.01% |
March 12, 2024 | -40.84% |
March 11, 2024 | -38.91% |
March 08, 2024 | -45.37% |
March 07, 2024 | -39.71% |
March 06, 2024 | -39.80% |
March 05, 2024 | -37.71% |
March 04, 2024 | -35.93% |
March 01, 2024 | -35.71% |
February 29, 2024 | -37.07% |
February 28, 2024 | -35.75% |
February 27, 2024 | -27.73% |
February 26, 2024 | -26.74% |
February 23, 2024 | -29.17% |
February 22, 2024 | -24.15% |
February 21, 2024 | -26.22% |
February 20, 2024 | -31.75% |
February 16, 2024 | -23.13% |
February 15, 2024 | -23.21% |
February 14, 2024 | 0.89% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.21%
Minimum
Nov 07 2022
301.5%
Maximum
Oct 14 2020
28.11%
Average
1.05%
Median
1 Year Total Returns (Daily) Benchmarks
Lexaria Bioscience Corp | -0.45% |
Acasti Pharma Inc | 2.73% |
Edesa Biotech Inc | -44.00% |
Xenon Pharmaceuticals Inc | 0.83% |
ESSA Pharma Inc | 128.4% |